Drug Profile
ZEN 3365
Alternative Names: ZEN 003365; ZEN3365Latest Information Update: 27 Apr 2023
Price :
$50
*
At a glance
- Originator Zenith Epigenetics
- Class Antineoplastics; Small molecules
- Mechanism of Action Bromodomain and extraterminal domain protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acute myeloid leukaemia; Lymphoproliferative disorders; Solid tumours
Most Recent Events
- 27 Apr 2023 Discontinued - Preclinical for Acute myeloid leukaemia in Canada (PO)
- 27 Apr 2023 Discontinued - Preclinical for Lymphoproliferative disorders in Canada (PO)
- 27 Apr 2023 Discontinued - Preclinical for Solid tumours in Canada (PO)